Cell Cytometry Market

Global Cell Cytometry Market (Focus on High Throughput Flow Cytometers and Image Cytometers) Distribution by Type of Cytometer, Company Size and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Lowest Price Guaranteed From USD 4,799

  • Companies Covered
    70

  • Pages
    220

  • View Count
    11927

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Cell Cytometry
3.2.1. Flow Cytometry
3.2.1.1. High Throughput Flow Cytometry

3.2.2 Image Cytometry

3.3. Advantages and Limitations of Cell Cytometry
3.4. Prevalent Trends Related to Cell Cytometry
3.4.1. Key Historical Trends 
3.4.2. Geographical Activity

4. HIGH THROUGHPUT FLOW CYTOMETERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. High Throughput Flow Cytometers: Overall Market Landscape
4.2.1. Analysis by Type of High Throughput Flow Cytometer 
4.2.2. Analysis by Throughput Rate
4.2.3. Analysis by Detection Rate
4.2.4. Analysis by Type of Plate Format(s)
4.2.5. Analysis by Number of Color Channels
4.2.6. Analysis by Number of Detection Channels 
4.2.7. Analysis by Number of Laser Channels
4.2.8. Analysis by Sample Volume
4.2.9. Analysis by Type of Detection Mechanism(s)
4.2.10 Analysis by Application(s)

4.3. High Throughput Flow Cytometers: Developer Landscape
4.3.1 Analysis by Year of Establishment
4.3.2 Analysis by Company Size
4.3.3 Analysis by Location of Headquarters
4.3.4 Most Active Players: Analysis by Number of Products Offered

5. PRODUCT COMPETITIVENESS ANALYSIS: HIGH THROUGHPUT FLOW CYTOMETERS
5.1. Chapter Overview
5.2. Assumptions / Key Parameters 
5.3. Methodology 
5.4. Product Competitiveness Analysis
5.4.1. Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Developers based in North America

5.4.2. Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Developers based in Europe and Asia-Pacific

6. IMAGE CYTOMETERS: MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Image Cytometers: Overall Market Landscape
6.2.1. Analysis by Type of Image Cytometer
6.2.2. Analysis by Processing Time
6.2.3. Analysis by Type of Plate Format(s)
6.2.4. Analysis by Output Format(s) 
6.2.5. Analysis by Sample Volume
6.2.6. Analysis by Application(s)

6.3. Image Cytometers: Developer Landscape
6.3.1. Analysis by Year of Establishment
6.3.2. Analysis by Company Size
6.3.3. Analysis by Location of Headquarters
6.3.4. Most Active Players: Analysis by Number of Products Offered

7. PRODUCT COMPETITIVENESS ANALYSIS: IMAGE CYTOMETERS
7.1. Chapter Overview
7.2. Assumptions / Key Parameters 
7.3. Methodology 
7.4. Product Competitiveness Analysis
7.4.1. Product Competitiveness Analysis: Image Cytometers offered by Developers based in North America
7.4.2. Product Competitiveness Analysis: Image Cytometers offered by Developers based in Europe and Asia-Pacific

8. GLOBAL CELL CYTOMETRY: COMPANY PROFILES
8.1. Chapter Overview
8.2. Agilent 
8.2.1. Company Overview
8.2.2. Recent Developments and Future Outlook

8.3. Beckman Coulter Life Sciences 
8.3.1. Company Overview
8.3.2. Recent Developments and Future Outlook

8.4. Becton Dickinson
8.4.1. Company Overview
8.4.2. Recent Developments and Future Outlook

8.5. Bio-Rad
8.5.1. Company Overview
8.5.2. Recent Developments and Future Outlook

8.6. Chemometec 
8.6.1. Company Overview
8.6.2. Recent Developments and Future Outlook

8.7. Milkotronic 
8.7.1. Company Overview
8.7.2. Recent Developments and Future Outlook

8.8. Nexcelom Bioscience 
8.8.1. Company Overview
8.8.2. Recent Developments and Future Outlook

8.9. Sartorius 
8.9.1. Company Overview
8.9.2. Recent Developments and Future Outlook

8.10. Sony Biotechnology
8.10.1. Company Overview
8.10.2. Recent Developments and Future Outlook

8.11. ThermoFisher Scientific
8.11.1. Company Overview
8.11.2. Recent Developments and Future Outlook

8.12. Union Biometrica
8.12.1. Company Overview
8.12.2. Recent Developments and Future Outlook

9. GLOBAL CELL CYTOMETYRY: PARTNERSHIPS AND COLLABORATIONS 
9.1. Chapter Overview
9.2. Partnership Models
9.3. List of Partnerships and Collaborations 
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Most Active Players: Analysis by Number of Partnerships
9.3.4. Regional Analysis 
9.3.5. Intercontinental and Intracontinental Agreements 

10. RECENT DEVELOPMENTS
10.1. Chapter Overview
10.2. Global Cell Cytometry: Funding and Investment Analysis 
10.2.1. Types of Funding 
10.2.2. Analysis by Year of Investment
10.2.3. Analysis by Type of Funding
10.2.4. Analysis by Amount Invested
10.2.5. Most Active Players: Analysis by Number of Funding Instances
10.2.6. Most Active Players: Analysis by Amount Raised
10.2.7. Most Active Investors: Analysis by Number of Funding Instances

10.3. Global Cell Cytometry: Global Event Analysis
10.3.1. Analysis by Year of Event
10.3.2. Analysis by Event Platform
10.3.3. Analysis by Type of Event
10.3.4. Analysis by Geography
10.3.5. Most Active Event Organizers: Analysis by Number of Events  
10.3.6. Most Active Organizations: Analysis by Number of Participants

10.4. Concluding Remarks

11. PATENT ANALYSIS 
11.1. Chapter Overview
11.2. Scope and Methodology
11.2.1. Analysis by Type of Patent
11.2.2. Analysis by Patent Publication Year
11.2.3. Analysis by Annual Number of Granted Patents and Patent Applications
11.2.4. Analysis by Geographical Location
11.2.5. Analysis by CPC Symbols
11.2.6. Analysis by Type of Organization
11.2.7. Leading Industry Players: Analysis by Number of Patents
11.2.8. Leading Non-Industry Players: Analysis by Number of Patents
11.2.9 Leading Individual Assignees: Analysis by Number of Patents

11.3. Cell Cytometry: Patent Benchmarking Analysis
11.3.1. Analysis by Patent Characteristics

11.4. Cell Cytometry: Patent Valuation Analysis
11.5. Leading Patents by Number of Citations

12. MARKET FORECAST
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Global Cell Cytometry Market, 2022-2035
12.3.1 Global Cell Cytometry Market: Distribution by Type of Cell Cytometer, 2022 and 2035
12.3.1.1. Cell Cytometry Market for High Throughput Flow Cytometers, 2022-2035
12.3.1.2. Cell Cytometry Market for Image Cytometers, 2022-2035

12.3.2. Global Cell Cytometry Market: Distribution by Company Size, 2022 and 2035
12.3.2.1. Cell Cytometry Market for Very Small Companies, 2022-2035
12.3.2.2. Cell Cytometry Market for Small Companies, 2022-2035
12.3.2.3. Cell Cytometry Market for Mid-sized Companies, 2022-2035
12.3.2.4. Cell Cytometry Market for Large Companies, 2022-2035
12.3.2.5. Cell Cytometry Market for Very Large Companies, 2022-2035

12.3.3. Global Cell Cytometry Market: Distribution by Key Geographical Regions, 2022 and 2035
12.3.3.1. Cell Cytometry Market in North America, 2022-2035
12.3.3.2. Cell Cytometry Market in Europe, 2022-2035
12.3.3.3. Cell Cytometry Market in Asia-Pacific, 2022-2035
12.3.3.4. Cell Cytometry Market in Rest of the World, 2022-2035

13. CONCLUDING REMARKS

14. EXECUTIVE INSIGHTS

15. APPENDIX 1: TABULATED DATA

16 APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 2.1 Executive Summary: High Throughput Flow Cytometers Market Landscape
Figure 2.2 Executive Summary: Image Cytometers Market Landscape 
Figure 2.3 Executive Summary: Partnerships and Collaborations
Figure 2.4 Executive Summary: Funding and Investment Analysis 
Figure 2.5 Executive Summary: Global Events
Figure 2.6 Executive Summary: Patent Analysis
Figure 2.7 Executive Summary: Market Forecast
Figure 3.1 Types of Cytometers
Figure 3.2 Advantages of Different Types of Cytometry
Figure 3.3 Limitations of Different Types of Cytometry
Figure 3.5 Google Trends: Historical Timeline
Figure 3.6 Google Trends: Geographical Activity
Figure 4.1 High Throughput Flow Cytometers: Distribution by Type of High Throughput Flow Cytometer
Figure 4.2 High Throughput Flow Cytometers: Distribution by Throughput Rate
Figure 4.3 High Throughput Flow Cytometers: Distribution by Detection Rate
Figure 4.4 High Throughput Flow Cytometers: Distribution by Type of Plate Format(s)
Figure 4.5 High Throughput Flow Cytometers: Distribution by Number of Color Channels
Figure 4.6 High Throughput Flow Cytometers: Distribution by Number of DetectionChannels
Figure 4.7 High Throughput Flow Cytometers: Distribution by Number of LaserChannels
Figure 4.8 High Throughput Flow Cytometers: Distribution by Sample Volume (in μl)
Figure 4.9 High Throughput Flow Cytometers: Distribution by Type of Detection Mechanism(s)
Figure 4.10 High Throughput Flow Cytometers: Distribution by Application(s)
Figure 4.11 High Throughput Flow Cytometer Developers: Distribution by Year of Establishment
Figure 4.12 High Throughput Flow Cytometer Developers: Distribution by Company Size
Figure 4.13 High Throughput Flow Cytometer Developers: Distribution by Location of Headquarters 
Figure 4.14 Leading High Throughput Flow Cytometer Developers: Distribution by Number of Products Offered
Figure 5.1 Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Players based in North America
Figure 5.2 Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Players based in Europe and Asia-Pacific
Figure 6.1 Image Cytometer: Distribution by Type of Image Cytometer
Figure 6.2 Image Cytometer: Distribution by Processing Time
Figure 6.3 Image Cytometer: Distribution by Type of Plate Format(s)
Figure 6.4 Image Cytometers: Distribution by Output Format(s)
Figure 6.5 Image Cytometers: Distribution by Sample Volume
Figure 6.6 Image Cytometer: Distribution by Application(s)
Figure 6.7 Image Cytometer Developers: Distribution by Year of Establishment
Figure 6.8 Image Cytometer Developers: Distribution by Company Size
Figure 6.9 Image Cytometer Developers: Distribution by Location of Headquarters
Figure 6.10 Leading Image Cytometer Developers: Distribution by Number of Products Offered
Figure 7.1 Product Competitiveness Analysis: Image Cytometers offered by Players based in North America
Figure 7.2 Product Competitiveness Analysis: Image Cytometers offered by Playersbased in Europe and Asia-Pacific
Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2017-2022
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2017-2022
Figure 9.4 Most Active Players: Distribution by Number of Partnerships
Figure 9.5 Partnerships and Collaborations: Regional Analysis 
Figure 9.6 Partnerships and Collaborations: Local and International Agreements
Figure 9.7 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 10.1 Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, 2017-2022
Figure 10.2 Funding and Investment Analysis: Distribution by Type of Funding
Figure 10.3 Funding and Investment Analysis: Cumulative Year-wise Distribution by Amount Invested, 2017-2022 (USD Million)
Figure 10.4 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
Figure 10.5 Funding and Investment Analysis: Year-Wise Distribution of Instances by Type of Funding and Total Amount Invested, 2017-2022 (USD Million)
Figure 10.6 Most Active Players: Distribution by Number of Funding Instances
Figure 10.7 Most Active Players: Distribution by Amount Raised (USD Million)
Figure 10.8 Most Active Investors: Distribution by Number of Funding Instances
Figure 10.9 Global Events: Cumulative Half yearly Trend, 2018 - H2 2022
Figure 10.10 Global Events: Distribution by Event Platform
Figure 10.11 Global Events: Distribution by Type of Event
Figure 10.12 Global Events: Regional Distribution of Events
Figure 10.13 Most Active Event Organizers: Distribution by Number of Events
Figure 10.14 Most Active Organizations: Distribution by Number of Participants
Figure 11.1 Patent Analysis: Distribution by Type of Patent
Figure 11.2 Patent Analysis: Cumulative Distribution by Publication Year, 2020-2022 Figure 11.3Patent Analysis: Cumulative Distribution by Annual Number of Granted 
Figure 11.4 Patent Analysis: Distribution by Geographical Location
Figure 11.5 Patent Analysis: Distribution by CPC Symbols
Figure 11.6 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization, 2020-2022 
Figure 11.7 Leading Industry Players: Distribution by Number of Patents
Figure 11.8 Leading Non-Industry Players: Distribution by Number of Patents
Figure 11.9 Leading Individual Assignees: Distribution by Number of Patents
Figure 11.10 Leading Players: Benchmarking by Patent Characteristics (CPC Symbols)
Figure 11.11 Patent Analysis: Year-wise Distribution of Patents by Age
Figure 11.12 Cell Cytometry: Patent Valuation Analysis
Figure 12.1 Global Cell Cytometry Market, 2022-2035 (USD Million) 
Figure 12.2 Global Cell Cytometry Market: Distribution by Type of Cell Cytometer,  2022 and 2035 
Figure 12.3 Cell Cytometry Market for High Throughput Flow Cytometers, 2022-2035 (USD Million) 
Figure 12.4 Cell Cytometry Market for Image Cytometers, 2022-2035 (USD Million)  
Figure 12.5 Global Cell Cytometry Market: Distribution by Company Size, 2022 and2035
Figure 12.6 Cell Cytometry Market for Very Small Companies, 2022-2035 (USD Million) 
Figure 12.7 Cell Cytometry Market for Small Companies, 2022-2035 (USD Million) 
Figure 12.8 Cell Cytometry Market for Mid-sized Companies, 2022-2035 (USD Million) 
Figure 12.9 Cell Cytometry Market for Large Companies, 2022-2035 (USD Million) 
Figure 12.10 Cell Cytometry Market for Very Large Companies, 2022-2035 (USD Million)
Figure 12.11 Global Cell Cytometry Market: Distribution by Key Geographical Regions, 2022 and 2035
Figure 12.12 Cell Cytometry Market in North America, 2022-2035 (USD Million)
Figure 12.13 Cell Cytometry Market in Europe, 2022-2035 (USD Million) 
Figure 12.14 Cell Cytometry Market in Asia-Pacific, 2022-2035 (USD Million) 
Figure 12.15 Cell Cytometry Market in Rest of the World, 2022-2035 (USD Million) 
Figure 13.1 Concluding Remarks: High Throughput Flow Cytometers Market Landscape
Figure 13.2 Concluding Remarks: Image Cytometers Market Landscape
Figure 13.3 Concluding Remarks: Partnerships and Collaborations
Figure 13.4 Concluding Remarks: Funding and Investment Analysis
Figure 13.5 Concluding Remarks: Global Events
Figure 13.6 Concluding Remarks: Patent Analysis
Figure 13.7 Concluding Remarks: Market Forecast

List Of Tables

Table 4.1 High Throughput Flow Cytometers: Information on Type of High  Throughput Flow Cytometer and Throughput Rate  
Table 4.2 High Throughput Flow Cytometers: Information on Detection Rate
Table 4.3 High Throughput Flow Cytometers: Information on Type of Plate Format(s) 
Table 4.4 High Throughput Flow Cytometers: Information on Number of Color Channels
Table 4.5 High Throughput Flow Cytometers: Information on Number of Detection Channels
Table 4.6 High Throughput Flow Cytometers: Information on Number of Laser Channels and Patented Technology
Table 4.7 High Throughput Flow Cytometers: Information on Availability of Automation, Availability of Automatic Sampling and Sample Volume
Table 4.8 High Throughput Flow Cytometers: Information on Type of Detection Mechanism(s)
Table 4.9 High Throughput Flow Cytometers: Information on Application(s)
Table 4.10 High Throughput Flow Cytometer Developers: Information on Year of Establishment, Company Size and Location of Headquarters
Table 6.1 Image Cytometer: Information on Type of Image Cytometer
Table 6.2 Image Cytometers: Information on Processing Time
Table 6.3 Image Cytometer: Information on Type of Plate Format(s) and Magnification
Table 6.4 Image Cytometer: Information on Output Format(s)
Table 6.5 Image Cytometer: Information on Sample Volume 
Table 6.6 Image Cytometers: Information on Application(s)
Table 6.7 Image Cytometer Developers: Information on Year of Establishment, Company Size and Location of Headquarters
Table 8.1 List of Companies Profiled
Table 8.2 Agilent: Company Overview
Table 8.3 Agilent: Recent Developments and Future Outlook
Table 8.4 Beckman Coulter Life Sciences: Company Overview
Table 8.5 Beckman Coulter Life Sciences: Recent Developments and Future Outlook
Table 8.6 Becton Dickinson: Company Overview
Table 8.7 Becton Dickinson: Recent Developments and Future Outlook
Table 8.8 Bio-Rad: Company Overview
Table 8.9 Bio-Rad: Recent Developments and Future Outlook
Table 8.10 Chemometec: Company Overview
Table 8.11 Chemotec: Recent Developments and Future Outlook
Table 8.12 Milkotronic: Company Overview
Table 8.13 Nexcelom Bioscinces: Company Overview
Table 8.14 Sartorius: Company Overview
Table 8.15 Sartorius: Recent Developments and Future Outlook
Table 8.16 Sony Biotechnology: Company Overview
Table 8.17 Thermo Fischer Scientific: Company Overview 
Table 8.18 Thermo Fischer Scientific: Recent Developments and Future Outlook
Table 8.19 Union Biometrica: Company Overview
Table 8.20 Union Biometrica: Recent Developments and Future Outlook
Table 9.1 Global Cell Cytometry: List of Partnerships and Collaborations, 2017-2022
Table 10.1 Global Cell Cytometry: List of Funding and Investments, 2017-2022
Table 10.2 Global Cell Cytometry: List of Global Events, 2018- 2022 
Table 11.1 Patent Analysis: Prominent CPC Symbols
Table 11.2 Patent Analysis: List of Top CPC Symbols
Table 11.3 Patent Analysis: Most Popular CPC Symbols
Table 11.4 Patent Analysis: Summary of Benchmarking Analysis
Table 11.5 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 11.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
Table 11.7 Patent Portfolio: List of Leading Patents (by Number of Citations) 
Table 15.1 High Throughput Flow Cytometers: Distribution by Type of High Throughput Flow Cytometer
Table 15.2 High Throughput Flow Cytometers: Distribution by Throughput Rate
Table 15.3 High Throughput Flow Cytometers: Distribution by Detection Rate
Table 15.4 High Throughput Flow Cytometers: Distribution by Type of Plate Format(s)
Table 15.5 High Throughput Flow Cytometers: Distribution by Number of Color Channels
Table 15.6 High Throughput Flow Cytometers: Distribution by Number of Detection Channels
Table 15.7 High Throughput Flow Cytometers: Distribution by Number  of Laser Channels
Table 15.8 High Throughput Flow Cytometers: Distribution by Sample Volume (in μl)
Table 15.9 High Throughput Flow Cytometers: Distribution by Type of Detection Mechanism(s)
Table 15.10 High Throughput Flow Cytometers: Distribution by Application(s)
Table 15.11 High Throughput Flow Cytometer Developers: Distribution by Year of Establishment
Table 15.12 High Throughput Flow Cytometer Developers: Distribution by Company Size
Table 15.13 High Throughput Flow Cytometer Developers: Distribution by Location of Headquarters 
Table 15.14 Leading High Throughput Flow Cytometer Developers: Distribution byNumber of Products Offered
Table 15.15 Image Cytometers: Distribution by Type of Image Cytometer
Table 15.16 Image Cytometers: Distribution by Processing Time
Table 15.17 Image Cytometers: Distribution by Type of Plate Format(s)
Table 15.18 Image Cytometers: Distribution by Output Format(s)
Table 15.19 Image Cytometers: Distribution by Sample Volume
Table 15.20 Image Cytometers: Distribution by Application(s)
Table 15.21 Image Cytometer Developers: Distribution by Year of Establishment
Table 15.22 Image Cytometer Developers: Distribution by Company Size
Table 15.23 Image Cytometer Developers: Distribution by Location of Headquarters
Table 15.24 Leading Image Cytometer Developers: Distribution by Number of Products Offered
Table 15.25 Partnerships and Collaborations: Cumulative Year-wise Trend, 2017-2022
Table 15.26 Partnerships and Collaborations: Distribution by Type of Partnership
Table 15.27 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2017-2022
Table 15.28 Most Active Players: Distribution by Number of Partnerships
Table 15.29 Partnerships and Collaborations: Regional Analysis 
Table 15.30 Partnerships and Collaborations: Local and International Agreements
Table 15.31 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 15.32 Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, 2017-2022
Table 15.33 Funding and Investment Analysis: Distribution by Type of Funding
Table 15.34 Funding and Investment Analysis: Cumulative Year-wise Distribution by Amount Invested, 2017-2022 (USD Million)
Table 15.35 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
Table 15.36 Funding and Investment Analysis: Year-Wise Distribution of Instances by Type of Funding and Total Amount Invested, 2017-2022 (USD Million)
Table 15.37 Most Active Players: Distribution by Number of Funding Instances
Table 15.38 Most Active Players: Distribution by Amount Raised (USD Million)
Table 15.39 Most Active Investors: Distribution by Number of Funding Instances
Table 15.40 Global Events: Cumulative Half yearly Trend, 2018 - H2 2022
Table 15.41 Global Events: Distribution by Event Platform
Table 15.42 Global Events: Distribution by Type of Event
Table 15.43 Global Events: Regional Distribution of Event
Table 15.44 Most Active Event Organizers: Distribution by Number of Events
Table 15.45 Most Active Organizations: Distribution by Number of Participants
Table 15.46 Patent Analysis: Distribution by Type of Patent
Table 15.47 Patent Analysis: Cumulative Distribution by Publication Year, 2020-2022
Table 15.48 Patent Analysis: Cumulative Distribution by Annual Number of Granted Patents and Patent Applications, 2020-2022 
Table 15.49 Patent Analysis: Distribution by Geographical Location
Table 15.50 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization, 2020-2022 
Table 15.51 Leading Industry Players: Distribution by Number of Patents
Table 15.52 Leading Non-Industry Players: Distribution by Number of Patents
Table 15.53 Leading Individual Assignees: Distribution by Number of Patents
Table 15.54 Leading Players: Benchmarking by Patent Characteristics (CPC Symbols)
Table 15.55 Patent Analysis: Year-wise Distribution of Patents by Age
Table 15.56 Cell Cytometry: Patent Valuation Analysis
Table 15.57 Global Cell Cytometry Market, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million) 
Table 15.58 Global Cell Cytometry Market: Distribution by Type of Cytometer, 2022 and 2035 
Table 15.59 Cell Cytometry Market for High Throughput Flow Cytometers, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million) 
Table 15.60 Cell Cytometry Market for Image Cytometers, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)  
Table 15.61 Global Cell Cytometry Market: Distribution by Company Size, 2022 and2035
Table 15.62 Cell Cytometry Market for Very Small Companies, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million) 
Table 15.63 Cell Cytometry Market for Small Companies, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million) 
Table 15.64 Cell Cytometry Market for Mid-Sized Companies, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million) 
Table 15.65 Cell Cytometry Market for Large Companies, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million) 
Table 15.66 Cell Cytometry Market for Very Large Companies, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million) 
Table 15.67 Global Cell Cytometry Market: Distribution by Key Geographical Regions, 2022 and 2035
Table 15.68 Cell Cytometry Market in North America, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million) 
Table 15.69 Cell Cytometry Market in Europe, 2022-2035, Conservative, Base and Optimistic Scenarios (USD Million) 
Table 15.70 Cell Cytometry Market in Asia-Pacific, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 15.71 Cell Cytometry Market in Rest of the World, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)

List Of Companies

The following companies and organizations have been mentioned in the report:

  1. 3E Bioventures
  2. 5 Prime Ventures
  3. Abacus dx
  4. Accellix
  5. ACEA Biosciences (acquired by Agilent)
  6. Agilent
  7. Ampersand Capital Partners
  8. Anzu Partners
  9. Beckman Coulter Life Sciences (acquired by Danaher)
  10. Becton Dickinson
  11. BennuBio
  12. BioLegend (a subsidiary of PerkinElmer)
  13. bioMérieux
  14. Bionovation Biotech
  15. Bioscribe
  16. Bio-Rad Laboratories
  17. Casdin Capital
  18. Chemometec
  19. Cottonwood Technology Fund
  20. Co-Win Ventures
  21. Cyberfreight Pharma Logistics
  22. Cytek Biosciences
  23. Cytobank
  24. Cytognos (acquired by Becton Dickinson)
  25. De Novo Software
  26. Diethelm Keller Siber Hegner (DKSH)
  27. Easy Prosperity
  28. Eight Roads Ventures
  29. FlowJo
  30. F-Prime Capital
  31. FusionX Ventures
  32. GE Healthcare
  33. Hillhouse Capital
  34. Illumina Ventures
  35. IncellDx
  36. Luminex (acquired by DiaSorin)
  37. LYFE Capital
  38. Merck
  39. MilliporeSigma
  40. Milkotronic
  41. Miltenyi Biotec
  42. Molecular Devices (acquired by Maureen Data Systems)
  43. NanoCellect Biomedical
  44. National Institutes of Health
  45. Nexcelom Bioscience (a subsidiary of PerkinElmer)
  46. Northern Light Venture Capital
  47. OrbiMed
  48. PerkinElmer
  49. Phitonex (acquired by Thermo Fisher Scientific)
  50. Polaris Biology
  51. Premas Life Sciences
  52. RA Capital
  53. SAGIAN Equity
  54. Sartorius
  55. Sony Biotechnology
  56. Stratedigm
  57. Sun Mountain Capital
  58. Sysmex
  59. Thermo Fisher Scientific
  60. ThinkCyte
  61. Thorlabs
  62. Tramway Venture Partners
  63. Union Biometrica
  64. Vala Sciences
  65. Vertical Venture Partners
  66. Virginia Venture Partners (a subsidiary of VIPC)
  67. Warburg Pincus
  68. Yokogawa
  69. Yonjin Capital (also known as Yonjin Venture)
  70. Qiagen

PRICING DETAILS

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more about Single-User License

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more about One Location Site License

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer Read more about Department License

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more about Enterprise License

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com